Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751998 · ClinicalTrials.gov registry record
Spy II Clinical Registry
A clinical trial of Biliary Tract Diseases, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 297
- Enrollment target
- 15
- Study locations
NCT00751998 is a study of Biliary Tract Diseases that has completed, run by Boston Scientific Corporation. The registered enrollment target is 297 participants. The trial reports 15 study locations across 10 states.
The verdict
NCT00751998, a study of Biliary Tract Diseases, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
- 15
- Study locations
Study Summary
A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.
Conditions Studied
Interventions
- DEVICE SpyGlass
Study Locations (15)
Other
- Erasme Hospital - Belgium - Brussels
- Bispebjerg Hospital, Denmark - København NV
- Hopital Edouard Herriot - Lyon
- Evangelisches Krankenhaus Dusseldorf - Düsseldorf
- Policlinico Agostino Gemelli - Roma
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
- University of Pittsburgh - Pittsburgh
California
- California Pacific Medical Center - San Francisco
Colorado
- University of Colorado Hospital - Aurora
Indiana
- Indiana University Medical Center - Indianapolis
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00751998
The ClinicalTrials.gov registry entry for NCT00751998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Biliary Tract Diseases appearing as the primary indexed condition, and to 1 intervention - of which SpyGlass is the first listed.
NCT00751998 reports 15 study locations spanning 10 distinct geographic areas - top geographies include Other, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT00751998 about?
NCT00751998 is a clinical study titled "Spy II Clinical Registry". A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.
What is the current status of trial NCT00751998?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2006-11. Estimated completion is 2009-10.
What conditions does trial NCT00751998 study?
This clinical trial studies the following conditions: Biliary Tract Diseases.
What interventions are being tested in trial NCT00751998?
The interventions under investigation include: SpyGlass (DEVICE).
Who is sponsoring clinical trial NCT00751998?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00751998 being conducted?
This trial has 15 study locations across California, Colorado, Indiana, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Tract Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.